The potential adding therapeutic effect of pentoxifylline and/or folic acid for chronic kidney disease patients: randomized controlled trial

Abstract Background/objectives Chronic kidney disease (CKD) is a highly prevalent, irreversible, and progressive disease associated with a high cardiovascular risk. We aimed to clinically investigate the extra-therapeutic effect of adding therapeutic doses of pentoxifylline (PTX) and/or folic acid (...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Amira Reda Muhammad Galal, Nahla Mohamed Teama, Karema Abu–Elfotuha, Ahmed D. Alatawi, Hanan Alshareef, Ahmed M. E. Hamdan, Ahmed Aljabri, Mohannad Alshibani, Zeinab AlKasaby Mahmoud Zalat
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2025-08-01
Serija:	BMC Nephrology
Teme:	Chronic kidney disease Clinical trials Folic acid Pentoxifylline Renal function parameters Anemia
Online dostop:	https://doi.org/10.1186/s12882-025-04399-3
Oznake:	Označite Brez oznak, prvi označite!